Second Quarter 2015 Financial Results

BioLight today reported operational and financial results for the second quarter ended June 30, 2015.

Operational Highlights:

  • Completed an upsized private investment and signed a strategic partnership with Rock-One International Holdings Ltd. designed to help BioLight maximize its presence within China, the second largest healthcare market in the world after the …

    Continue reading

Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ

BioLight today announced that its cancer diagnostics subsidiary, Micromedic Technologies, has identified several new genetic markers with high potential to predict necrosis of the jawbone in patients treated with bisphosphonate drugs and was able to repeat findings from a previous study for one significant marker in a larger and more diversified group …

Continue reading

Collaboration with Ora, Inc. for TeaRx™

BioLight today announced that it has expanded its relationship with Ora, Inc., a world-leading independent, full-service ophthalmic contract research organization and product development firm, via the signing of a collaboration agreement pursuant to which the companies will work together to advance the clinical, regulatory and commercial development of BioLight’s TeaRx™ …

Continue reading

First Quarter 2015 Financial Results

BioLight today reported operational and financial results for the first quarter ended March 31, 2015.

Operational Highlights:

  • Reported clinical study findings that identified positive statistical correlations between the TeaRx™ test’s diagnostic parameters and widely used benchmark tests for dry eye syndrome.
  • Reported that a blinded, multi-center clinical study of …

    Continue reading

BioLight Has Completed an Upsized Private Placement

BioLight announced today that it has completed an upsized private placement as part of the strategic partnership with Rock-One International Holdings Ltd for aggregate gross proceeds of US$6.6 million.

The strategic partnership along with the private placement was previously announced on April 2, 2015.  The offering resulted in the issuance …

Continue reading

First IOPtiMate™ System Sale in Hungary

BioLight announces the first sale of an IOPtiMate™ system to a medical center located in Hungary.

The sale of the first system in Hungary is a result of a marketing campaign to leading physicians and medical centers mainly in Asia and Europe for the IOPtiMate™ system as part of the …

Continue reading